ZURA Logo
ZURA
Zura Bio Ltd - Class A
$6.51
-1.44%
Company Details
Name

Zura Bio Ltd

Website

-

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in Biotechnology

Categories

CEO

-

Employees

7

Description

zura bio is a clinical-stage biotechnology company advancing zb-168 in alopecia areata and other inflammatory diseases. zb-168 is an anti il7rα inhibitor that has the potential to impact diseases driven by il7 and tslp biological pathways. zura bio aims to develop a portfolio of therapeutic indications for zb-168, and is focused on demonstrating its efficacy, safety, dosing convenience and mechanism of action, initially in alopecia areata. this will build on phase 1b data in type 1 diabetes demonstrating a favourable safety profile and strong biological rationale. zura bio is headquartered in london, uk with team members in the uk and usa.

Stock Quote
Market Cap

$283.58M

52 Week High

$37.55

PE Ratio

-

52 Week Low

$4.87

EPS

-

Shares Outstanding

43.59M

Dividend Yield

-

Dividend Per Share

-

Company Details
Name

Zura Bio Ltd

Website

-

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in Biotechnology

Categories

CEO

-

Employees

7

Description

zura bio is a clinical-stage biotechnology company advancing zb-168 in alopecia areata and other inflammatory diseases. zb-168 is an anti il7rα inhibitor that has the potential to impact diseases driven by il7 and tslp biological pathways. zura bio aims to develop a portfolio of therapeutic indications for zb-168, and is focused on demonstrating its efficacy, safety, dosing convenience and mechanism of action, initially in alopecia areata. this will build on phase 1b data in type 1 diabetes demonstrating a favourable safety profile and strong biological rationale. zura bio is headquartered in london, uk with team members in the uk and usa.

Latest News
Related Stocks